PICO 7: treatment: direct acting antiviral therapy versus pegylated interferon and ribavirin treatment for chronic hepatitis C infection: a meta-analytical systematic review
عرض/
الإستشهاد
(2014). PICO 7: treatment: direct acting antiviral therapy versus pegylated interferon and ribavirin treatment for chronic hepatitis C infection: a meta-analytical systematic review. World Health Organization. https://apps.who.int/iris/handle/10665/133714
الوصف
Annex to Guidelines for the screening, care and treatment of persons with hepatitis C infection ISBN 9789241548755Gov't Doc #
WHO/HIV/2014.33اللغة
Englishالمجموعات
البيانات
عرض سجل كامل للمادةمواد ذات صلة
عرض المواد ذات الصلة حسب العنوان، إسم المؤلف والموضوع.
-
Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major
(2009)Treatment of chronic hepatitis C virus [HCV] infection in transfusion-dependent betathalassaemia major patients is complicated by existing hepatic siderosis and the fear of ribavirinassociated haemolysis. We evaluated the efficacy and side-effects of combination interferon-alpha [INF] and ribavirin therapy for HCV-infected thalassaemia patients. A total of 17 patients were enrolled [10 nonresponders to INF monotherapy, 7 naive to treatment, mean age 23.1 years] and they received 12 months of combination therapy. The sustained virological response ... -
PICO 7 treatment (pegylated interferon and ribavirin vs DAAs): decision making table
(2014, WHO/HIV/2014.40)
